Cargando…
Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
The application of pharmacogenetics in oncology is part of the routine clinical practice. In particular, genotyping of dihydropyrimidine dehydrogenase (DPYD) and UDP-glucuronosyltransferase (UGT1A1) is crucial to manage the treatment of patients taking fluoropyrimidines and irinotecan. The unique ap...
Autores principales: | Montrasio, Cristina, Cheli, Stefania, Clementi, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390719/ https://www.ncbi.nlm.nih.gov/pubmed/37534027 http://dx.doi.org/10.2147/PGPM.S412430 |
Ejemplares similares
-
LightSNiP assay is a good strategy for pharmacogenetics test
por: Cheli, Stefania, et al.
Publicado: (2015) -
Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase
por: Falvella, Felicia Stefania, et al.
Publicado: (2015) -
Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomas
por: Loni, L, et al.
Publicado: (2001) -
Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics
por: Adhikari, Archana, et al.
Publicado: (2021) -
Pharmacogenetics of anticancer monoclonal antibodies
por: Shek, Dmitrii, et al.
Publicado: (2019)